公司资料
MediciNova 股价、新闻与催化剂
- 股票代码:
- MNOV
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
3.45 USD (+36.90%)
收盘价
最后更新: 2026年9月17日
66M USD
市值
股价为何变动
截至 2026年9月17日，MNOV 上涨 36.9%，收于 $3.45。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
MediciNova is a biotechnology company with programs in inflammation, fibrosis, and neurological disease. Its story is built around repurposing and selective development rather than broad commercial scale.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, MediciNova sits in specialty biotechnology.
商业模式特征
The company depends on clinical data, pipeline prioritization, and the chance to build value from a narrow set of programs.
生物医药行业定位
MediciNova is a small-cap biotech name whose valuation depends on a few clinical catalysts.
未来催化剂
- MediciNova’s catalysts are its repurposed pipeline assets and any strategic update that clarifies which programs still matter. The company needs a clearer clinical path to regain attention.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。